The invention features an immunogenic composition containing a frequently-recognized
epitope of an HIV-1 accessory protein such as Vpr and methods of inducing an immune
response using such an epitope. The epitope peptide contains the amino acid sequence
ALIRILQQL of a functionally active domain or a structural domain of the accessory protein.